INMB Operating Cash Flow (Statement)
Inmune Bio Inc · Operating Cash Flow (Statement)
INMB Operating Cash Flow (Statement)
Latest reported-$14.97Mperiod ending
INMB TTM Cash from Operations (-$761.83K → -$14.97M)
TTM operating cash flow (statement)
High-resolution chart · PNG
INMB operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -14,972,000 | |
| -19,172,000 | |
| -22,593,000 | |
| -30,651,000 | |
| -32,198,000 | |
| -32,709,000 | |
| -33,361,000 | |
| -25,749,000 | |
| -23,027,000 | |
| -18,315,000 | |
| -11,980,000 | |
| -14,274,000 | |
| -13,377,000 | |
| -14,962,000 | |
| -22,686,000 | |
| -26,771,000 | |
| -31,327,000 | |
| -32,277,000 | |
| -28,504,000 | |
| -21,116,713 | |
| -16,891,552 | |
| -13,000,750 | |
| -8,943,646 | |
| -6,984,303 | |
| -5,232,225 | |
| -5,031,850 | |
| -5,384,656 | |
| -5,413,663 | |
| -3,917,831 | |
| -3,117,855 | |
| -2,058,994 | |
| -1,971,977 | |
| -1,676,679 | |
| -946,644 | |
| -761,834 | |
| -634,016 | |
| -479,385 |